Pain Medication

Narcotic Pain Medication

Pain Killer Addition

Using Medication to Manage Pain and Reduce Sleep Problems

Ben Parr — Mon, 02 Feb 2009 12:37:10 -0800

If behavior changes and environment have not proven to be sufficient sleep aids, patients should discuss with their physician whether over-the-counter or prescription drugs should be used to treat their pain, improve their sleep or both.

Psychological Techniques, Sleep Environment, and Better Sleep

Ben Parr — Mon, 02 Feb 2009 12:37:08 -0800

Two additional sleep aids include utilizing psychological approaches to reduce pain and fall asleep and setting up a sleep-conducive environment.

Using psychological approaches to minimize pain at bedtime

"Mind over matter” can help patients override or re-balance pain signals with more pleasant, sleep-inducing thoughts. A few techniques that have proven successful are:

Types of NSAIDs

Greg — Mon, 05 May 2008 11:55:00 -0700

The following provides a more comprehensive list of different types of NSAIDs. Please see Most Common Types of NSAIDs for a more in-depth review of the common NSAIDs.

Types of NSAIDs

Generic name

Brand name(s)

Salicylic acids

Potential Risks and Complications of NSAIDs

Greg — Mon, 05 May 2008 11:51:11 -0700

As with any medication, there are a number of potential risks, side effects and complications that it patients need to be aware of prior to starting to take the any form of the medication.

Vioxx Recall and Recommendations

spine-health — Mon, 17 Dec 2007 08:42:13 -0800

In late September 2004, Vioxx—a brand of COX-2 inhibitor commonly prescribed for arthritis, acute pain and several types of back pain—was withdrawn from the market. The Vioxx recall occurred after Merck, the drug’s manufacturer, reported findings of increased risk of heart attack and stroke among participants in an ongoing clinical trial. The U.S. Food and Drug Administration (FDA) did not require a Vioxx recall; Merck voluntarily pulled Vioxx from the market on September 30, 2004.

Accelerated Opiate Neuro-Regulation Rapid Detoxification

spine-health — Mon, 17 Dec 2007 08:42:13 -0800

More Pain Medication Info

Narcotic Pain Medication

Pain Killer Addition

Patients with the following characteristics may be a candidate for accelerated opiate neuro-regulation form of rapid detoxification:

Rapid Opiate Detoxification Treatment

spine-health — Mon, 17 Dec 2007 08:42:13 -0800

Medical treatment strategies for opiate addiction have evolved since the 1950’s, when methadone was first used to aid withdrawal. Methadone maintenance programs, in which patients are given methadone, another opiate, as a substitute for the drug of dependence, have been a mainstay of opiate addiction treatment for decades. Now other drugs, like buprenorphine, are given in a similar way to be a substitute for the drug of addiction. For the majority of patients this is not an acceptable alternative, because the physical dependence continues, and is often a lifelong commitment.

Sleep Aids for People with Chronic Pain

spine-health — Mon, 17 Dec 2007 08:42:13 -0800

Whether it is the inability to fall asleep, to stay asleep for the recommended seven to eight hours, or waking too early (for example, 4 a.m. versus 6 a.m.), chronic pain can cause sleep problems in a number of ways. Lack of sleep can worsen pain, and of course more intense pain then continues to interfere with sleep, so the two symptoms can become a vicious cycle.

Pain Killer Addiction Treatment

spine-health — Mon, 17 Dec 2007 08:42:13 -0800

More Pain Medication Info

Narcotic Pain Medication

References

spine-health — Mon, 17 Dec 2007 08:42:13 -0800

References

Albanese AP, Gevirtz C, Oppenheim B, Field JM, Abels I, Eustace JC. Outcome and Six Month Follow Up of Patients After Ultra Rapid Opiate Detoxification (UROD). J Addict Dis. 2000;19(2):11-28. ABSTR ONLY.
American Society of Addiction Medicine Public Policy Statement on Rapid and Ultra Rapid Opioid Detoxification. April 2005.
read more

About Celebrex and Bextra

spine-health — Mon, 17 Dec 2007 08:42:12 -0800

On April 7, 2005 the Food and Drug Administration requested that Pfizer suspend sales of Bextra in the United States. As a result, Bextra will no longer be available to patients in the United States.

Since the September 2004 recall of Vioxx, recent studies have raised questions about the potential side effects of COX-2 inhibitors. For more information, please see Understanding COX-2 Inhibitor Side Effects.

Narcotic Pain Medications

spine-health — Mon, 17 Dec 2007 08:42:12 -0800

More Pain Medication Info